246529-22-6 | Aramchol (Catalog# : 6111903)Galmed Pharmaceuticals Announces Successful Completion of End of Phase 2 Meeting With FDA and Plan for Start of Phase 3 NEWS PROVIDED BYGalmed Pharmaceuticals Ltd.09 Apr, 2019, 1
2097416-76-5 | AZD0364 (Catalog# : 192275)AZD0364 is an ERK1 and/or ERK2 kinase for the treatment of cancer. ERK1 and ERK2 kinases are ubiquitously expressed MAPK kinases that participate in the RAS-RAF-MEK-ERK signa
2248003-60-1 | AZD3229 (Catalog# : 191287)AZD3229 is a potent pan-KIT mutant inhibitor for the treatment of gastrointestinal stromal tumors. AZD3229 demonstrates potent single digit nM growth inhibition across a broad ce
297730-17-7 | AVN944 (Catalog# : 022201)AVN944 is an orally available, synthetic small molecule with potential antineoplastic activity, which inhibits inosine monosphosphate dehydrogenase (IMPDH), an enzyme involved in
252025-52-8 | Adjudin (Catalog# : 122824)Adjudin is a drug which is under development as a potential non-hormonal male contraceptive drug, which acts by blocking the production of sperm in the testes, but without affect
256925-03-8 | AL 082D06 (Catalog# : 101921)AL 082D06(D-06) is the first selective, nonsteroidal glucocorticoid receptor (GR) antagonist with Ki of 210 nM, exhibits excellent selectivity against AR, PR, MR and ER(Ki > 1
219766-25-3 | ANA-12 (Catalog# : 101910)ANA-12 is aTrkB receptor antagonist, which showed direct and selective binding to TrkB and inhibited processes downstream of TrkB without altering TrkA and TrkC functions.